Expertise in
2
conditions

Dr. Chad E. Miller

General Practice
1375 E 20th Ave, 
Denver, CO 
Expertise in
2
conditions
1375 E 20th Ave, 
Denver, CO 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Chad Miller is a primary care provider, practicing in General Practice in Denver, Colorado. Dr. Miller is highly rated in 2 conditions, according to our data. His top areas of expertise are Pulmonary Hypertension, Hypertension, Cardiomyopathy, Dilated Cardiomyopathy (DCM), and Thrombectomy.

His clinical research consists of co-authoring 19 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
General Practice
Licenses
General Practice in CO
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

1375 E 20th Ave, Denver, CO 80205

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Active_not_recruiting
Publish Date: June 24, 2025
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
A Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension
Enrollment Status: Terminated
Publish Date: June 04, 2025
Intervention Type: Drug
Study Phase: Phase 3
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
ADAPT - A Patient Registry of the Real-world Use of Orenitram®
Enrollment Status: Active_not_recruiting
Publish Date: March 28, 2025
Intervention Type: Drug
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
EXPEDITE: A 16-Week, Multicenter, Open-label Study of Remodulin Induction Followed by Orenitram Optimization in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 07, 2023
Intervention Type: Drug
Study Drug: Intravenous/Subcutaneous Treprostinil
Study Phase: Phase 4
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Open-Label Extension Study of UT-15C in Subjects With Pulmonary Arterial Hypertension- A Long-Term Follow-Up to Protocol TDE-PH-310
Enrollment Status: Completed
Publish Date: June 02, 2022
Intervention Type: Drug
Study Drug: UT-15C
Study Phase: Phase 3
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
A Phase III, International, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Clinical Worsening Study of UT-15C in Subjects With Pulmonary Arterial Hypertension Receiving Background Oral Monotherapy
Enrollment Status: Completed
Publish Date: February 13, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

19 Total Publications

Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus.
Practical management of oral treprostinil in patients with pulmonary arterial hypertension: Lessons from ADAPT, EXPEDITE, and expert consensus.
Journal: Respiratory medicine
Published: March 07, 2024
Similar Doctors
Expertise in
34
conditions
Dr. Jameel R. Chohan
General Practice | Internal Medicine
Expertise in
34
conditions
Dr. Jameel R. Chohan
General Practice | Internal Medicine

Meadows Family Medical Center Inc

999 17th St, Suite 500, 
Denver, CO 
 (1.5 miles away)
720-355-0539
Languages Spoken:
English
See accepted insurances

Jameel Chohan is a primary care provider, practicing in General Practice and Internal Medicine in Denver, Colorado. Dr. Chohan is highly rated in 34 conditions, according to our data. His top areas of expertise are Dementia, Alcoholic Neuropathy, Chronic Obstructive Pulmonary Disease (COPD), and Type 2 Diabetes (T2D).

Expertise in
5
conditions
Dr. Daniel M. Witt
General Practice
Expertise in
5
conditions
Dr. Daniel M. Witt
General Practice
16601 E Centretech Pkwy, 
Aurora, CO 
 (9.5 miles away)
720-536-7930
Languages Spoken:
English
See accepted insurances

Daniel Witt is a primary care provider, practicing in General Practice in Aurora, Colorado. Dr. Witt is highly rated in 5 conditions, according to our data. His top areas of expertise are Venous Thromboembolism (VTE), Gastrointestinal Bleeding, Deep Vein Thrombosis, Hip Replacement, and Knee Replacement.

Expertise in
3
conditions
Dr. Michael C. Steiner
Internal Medicine | General Practice
Expertise in
3
conditions
Dr. Michael C. Steiner
Internal Medicine | General Practice
8181 E Tufts Ave Ste 560, 
Denver, CO 
 (8.2 miles away)
720-669-3470
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Steiner is a primary care provider, practicing in Internal Medicine and General Practice in Denver, Colorado. Dr. Steiner is highly rated in 3 conditions, according to our data. His top areas of expertise are Chronic Obstructive Pulmonary Disease (COPD), Emphysema, Cerebral Hypoxia, Osteotomy, and Endoscopy. Dr. Steiner is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Miller's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile